These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19806853)

  • 21. Differences by age and race/ethnicity in knowledge about hypercholesterolemia.
    Kaplan RC; Bhalodkar NC; Brown DL; White J; Brown EJ
    Cardiol Rev; 2006; 14(1):1-6. PubMed ID: 16371759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
    Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
    BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new reality: achieving cholesterol-lowering goals in clinical practice.
    Gaw A
    Atheroscler Suppl; 2002 Apr; 2(4):5-8; discussion 8-11. PubMed ID: 11976071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study.
    Ogedegbe G; Harrison M; Robbins L; Mancuso CA; Allegrante JP
    Ethn Dis; 2004; 14(1):3-12. PubMed ID: 15002917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Access to Care, Treatment Ambivalence, Medication Nonadherence, and Long-Term Mortality Among Severely Hypertensive African Americans: A Prospective Cohort Study.
    Young JH; Ng D; Ibe C; Weeks K; Brotman DJ; Dy SM; Brancati FL; Levine DM; Klag MJ
    J Clin Hypertens (Greenwich); 2015 Aug; 17(8):614-21. PubMed ID: 25923581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.
    García Ruiz FJ; Marín Ibáñez A; Pérez-Jiménez F; Pintó X; Nocea G; Ahumada C; Alemao E; Yin D;
    Pharmacoeconomics; 2004; 22 Suppl 3():1-12. PubMed ID: 15669149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.
    Mathews R; Wang TY; Honeycutt E; Henry TD; Zettler M; Chang M; Fonarow GC; Peterson ED;
    Am Heart J; 2015 Jul; 170(1):62-9. PubMed ID: 26093865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disparities in Statin Use in New York City: Implications for Health Reform.
    Allende C; Gusmano MK; Weisz D
    J Racial Ethn Health Disparities; 2019 Jun; 6(3):463-471. PubMed ID: 30456578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender Disparities in Lipid-Lowering Therapy in Cardiovascular Disease: Insights from a Managed Care Population.
    Rodriguez F; Olufade TO; Ramey DR; Friedman HS; Navaratnam P; Heithoff K; Foody JM
    J Womens Health (Larchmt); 2016 Jul; 25(7):697-706. PubMed ID: 26889924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy.
    Benner JS; Chapman RH; Petrilla AA; Tang SS; Rosenberg N; Schwartz JS
    Am J Health Syst Pharm; 2009 Aug; 66(16):1471-7. PubMed ID: 19667004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cluster randomized controlled Trial to Evaluate an Ambulatory primary care Management program for patients with dyslipidemia: the TEAM study.
    Villeneuve J; Genest J; Blais L; Vanier MC; Lamarre D; Fredette M; Lussier MT; Perreault S; Hudon E; Berbiche D; Lalonde L
    CMAJ; 2010 Mar; 182(5):447-55. PubMed ID: 20212029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New clinical perspectives of hypolipidemic drug therapy in severe hypercholesterolemia.
    Stefanutti C; Morozzi C; Di Giacomo S
    Curr Med Chem; 2012; 19(28):4861-8. PubMed ID: 22963620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beliefs about prescription medications among patients with diabetes: variation across racial groups and influences on cost-related medication underuse.
    Piette JD; Heisler M; Harand A; Juip M
    J Health Care Poor Underserved; 2010 Feb; 21(1):349-61. PubMed ID: 20173274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients' perspective of barriers and facilitators to taking long-term controller medication for asthma: a novel taxonomy.
    Peláez S; Lamontagne AJ; Collin J; Gauthier A; Grad RM; Blais L; Lavoie KL; Bacon SL; Ernst P; Guay H; McKinney ML; Ducharme FM
    BMC Pulm Med; 2015 Apr; 15():42. PubMed ID: 25907709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, factors influencing and knowledge about adherence to lipid-lowering therapy among hyperlipidemia patients.
    Devaraj NK; Mohamed M; Hussein N
    Med J Malaysia; 2017 Jun; 72(3):157-164. PubMed ID: 28733563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication adherence beliefs of community-dwelling hypertensive African Americans.
    Lewis LM; Askie P; Randleman S; Shelton-Dunston B
    J Cardiovasc Nurs; 2010; 25(3):199-206. PubMed ID: 20386242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to lipid-lowering agents among 11,042 patients in clinical practice.
    Wong MC; Jiang JY; Griffiths SM
    Int J Clin Pract; 2011 Jul; 65(7):741-8. PubMed ID: 21676117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Freedom of choice and adherence to the health regimen for African Americans with hypertension.
    Abel WM; Barksdale DJ
    ANS Adv Nurs Sci; 2012; 35(4):E1-8. PubMed ID: 22918261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extent of control of cardiovascular risk factors and adherence to recommended therapies in US multiethnic adults with coronary heart disease: from a 2005-2006 national survey.
    Vulic D; Lee BT; Dede J; Lopez VA; Wong ND
    Am J Cardiovasc Drugs; 2010; 10(2):109-14. PubMed ID: 20334448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.